Jericho Assisted Living
Thursday, February 2, 2017
PCSK9 Inhibitor Delivers Key CV Benefits in First Outcomes Trial
(MedPage Today) -- Positive topline results announced for FOURIER
via
PCSK9 Inhibitor Delivers Key CV Benefits in First Outcomes Trial
by
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment